1. Faisal, Syed M, Castro, Maria G, Lowenstein, Pedro R. 2023. Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 2839-2860. doi:10.1016/j.ymthe.2023.08.009. https://pubmed.ncbi.nlm.nih.gov/37574780/
2. Momenilandi, Mana, Lévy, Romain, Sobrino, Steicy, Casanova, Jean-Laurent, Béziat, Vivien. 2024. FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice. In Cell, 187, 2817-2837.e31. doi:10.1016/j.cell.2024.04.009. https://pubmed.ncbi.nlm.nih.gov/38701783/
3. Cueto, Francisco J, Sancho, David. 2021. The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy. In Cancers, 13, . doi:10.3390/cancers13071525. https://pubmed.ncbi.nlm.nih.gov/33810248/
4. Barry, Kevin C, Hsu, Joy, Broz, Miranda L, Chan, Vincent, Krummel, Matthew F. 2018. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. In Nature medicine, 24, 1178-1191. doi:10.1038/s41591-018-0085-8. https://pubmed.ncbi.nlm.nih.gov/29942093/
5. Yao, Lun, Hu, Qiao, Chen, Siqi, Fan, Shengxian, He, Qigai. 2021. Recombinant Pseudorabies Virus with TK/gE Gene Deletion and Flt3L Co-Expression Enhances the Innate and Adaptive Immune Response via Activating Dendritic Cells. In Viruses, 13, . doi:10.3390/v13040691. https://pubmed.ncbi.nlm.nih.gov/33923590/
6. Faisal, Syed M, Mendez, Flor M, Nunez, Fernando, Castro, Maria G, Lowenstein, Pedro R. 2020. Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas. In Oncotarget, 11, 4607-4612. doi:10.18632/oncotarget.27834. https://pubmed.ncbi.nlm.nih.gov/33400737/
智鼠故事 
